About the Authors

Adrianne L. Jenner

Roles Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft

adrianne.jenner@qut.edu.au

Affiliation School of Mathematical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia

Robyn P. Araujo

Roles Methodology, Writing – review & editing

Affiliation School of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia

Noa L. Levi

Roles Formal analysis, Writing – original draft

Affiliation School of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia

Guy Ungerechts

Roles Resources, Writing – review & editing

Affiliations Clinical Cooperation Unit “Virotherapy”, German Cancer Research Center (DKFZ), Heidelberg, Germany, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany, Department of Medical Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany

Christine E. Engeland

Roles Conceptualization, Data curation, Investigation, Resources, Writing – review & editing

Affiliation Experimental Hematology and Immunotherapy, Department of Hematology, Hemostaseology, Cellular Therapy and Infectious Diseases, Faculty of Medicine and Leipzig University Hospital, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany

Johannes P. W. Heidbuechel

Roles Conceptualization, Data curation, Investigation, Resources, Writing – original draft, Writing – review & editing

Affiliations Clinical Cooperation Unit “Virotherapy”, German Cancer Research Center (DKFZ), Heidelberg, Germany, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: Dr Engeland is listed as inventor on patents filed by her former institution describing immunomodulatory oncolytic viruses. G.U. is founder and current CMO/CSO of CanVirex, Basel, Switzerland and reports grants or contracts from DFG, German Cancer Aid, and Wilhelm Sander Foundation and consulting fees from Boehringer Ingelheim. Apart from this, the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.